Solstein Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Buy |
1,516
+140
| +10% | +$109K | 0.61% | 40 |
|
|
2025
Q1 | $1.14M | Sell |
1,376
-80
| -5% | -$66.1K | 0.66% | 37 |
|
|
2024
Q4 | $1.12M | Hold |
1,456
| – | – | 0.63% | 43 |
|
|
2024
Q3 | $1.29M | Sell |
1,456
-93
| -6% | -$82.4K | 0.68% | 37 |
|
|
2024
Q2 | $1.4M | Sell |
1,549
-74
| -5% | -$67K | 0.92% | 30 |
|
|
2024
Q1 | $1.26M | Sell |
1,623
-11
| -0.7% | -$8.56K | 0.88% | 29 |
|
|
2023
Q4 | $952K | Hold |
1,634
| – | – | 0.7% | 36 |
|
|
2023
Q3 | $878K | Hold |
1,634
| – | – | 0.75% | 38 |
|
|
2023
Q2 | $766K | Buy |
1,634
+74
| +5% | +$34.7K | 0.64% | 41 |
|
|
2023
Q1 | $536K | Sell |
1,560
-575
| -27% | -$197K | 0.47% | 46 |
|
|
2022
Q4 | $781K | Buy |
2,135
+691
| +48% | +$253K | 0.65% | 37 |
|
|
2022
Q3 | $467K | Hold |
1,444
| – | – | 0.41% | 54 |
|
|
2022
Q2 | $468K | Hold |
1,444
| – | – | 0.36% | 58 |
|
|
2022
Q1 | $414K | Buy |
1,444
+661
| +84% | +$190K | 0.27% | 80 |
|
|
2021
Q4 | $216K | Sell |
783
-122
| -13% | -$33.7K | 0.13% | 124 |
|
|
2021
Q3 | $209K | Hold |
905
| – | – | 0.12% | 128 |
|
|
2021
Q2 | $208K | Buy |
905
+530
| +141% | +$122K | 0.26% | 94 |
|
|
2021
Q1 | $70K | Buy |
+375
| New | +$70K | 0.1% | 179 |
|
|
2020
Q4 | – | Sell |
-319
| Closed | -$47K | – | 153 |
|
|
2020
Q3 | $47K | Hold |
319
| – | – | 0.11% | 134 |
|
|
2020
Q2 | $52K | Hold |
319
| – | – | 0.12% | 112 |
|
|
2020
Q1 | $44K | Buy |
319
+61
| +24% | +$8.41K | 0.17% | 89 |
|
|
2019
Q4 | $34K | Buy |
+258
| New | +$34K | 0.07% | 137 |
|